Tau experimental models: effects of amyloid beta oligomers on tau pathology
Jonathan Brouillette(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Luc Buée(Inserm), Karim Bélarbi(Inserm), Inna Kuperstein(Inserm), Detlef Balschun(KU Leuven), David Blum(University of Tübingen), Ann Van der Jeugd(KU Leuven), Tariq Ahmed(Capital University of Science and Technology), Rudi D’Hooge, Sylvie Burnouf, Bart De Strooper(VIB-KU Leuven Center for Brain & Disease Research)
Unknown
January 1, 2009
Cited by 1
Related Papers
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k